RxDoctor Payments DataLook up a doctor →

Donavon Wewers, MD

Internal Medicine · Dothan, ALNPI 1972558773

Payments from drug & device makers

$1,254,669in general payments, 2019–2025

Across 112 payments — averaging $11,202 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$777K
  • AstraZeneca$476K
  • Abbott$291
  • AbbVie$203
  • GSK$187
  • Novo Nordisk$151
  • plus $645 from 18 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,254,669 in reported general payments places this provider in the 95th percentile of 1,533 internal medicine providers in Alabama.

See all internal medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$636,106
Medicare patients
1,773
Services billed
20,000

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Dothan

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →